New ACS Report: Breast Cancer Mortality Continues Three Decade Decline Overall, but Steeper Increases in Incidence for Women <50 & Asian American, Pacific Islanders of all Ages

The American Cancer Society (ACS) today released Breast Cancer Statistics, 2024, the organization’s biennial update on breast cancer occurrence and trends in the United States. The new report finds breast cancer mortality rates overall have dropped by 44% since 1989, averting approximately 517,900 breast cancer deaths. However, not all women have benefited from this progress, notably American Indian and Alaska Native (AIAN) women, whose rates have remained unchanged over the past three decades

Penn Medicine Brings Free 3D Mammograms and Health Screenings Back to West Philly

Penn Medicine will once again join with community partners and Siemens Healthineers to host a free mammogram clinic and community health fair in June, giving the West Philadelphia and Upper Darby communities convenient access to health screenings right in their neighborhoods.

New breast cancer screening recommendations aim to address health inequities, especially among Black women

Challenges remain in ensuring equitable access to screening and addressing gaps in evidence regarding supplemental screening modalities and the adoption of artificial intelligence (AI) technologies, notes Joann Elmore, MD, MPH, a professor of medicine at the David Geffen School of Medicine at UCLA in a newly published editorial in JAMA.

MD Anderson launches collaborative initiative to reduce breast cancer disparities in Houston area

The University of Texas MD Anderson Cancer Center launches a community-wide health care initiative to reduce breast cancer disparities in the Houston area, particularly for Black women. Texas Health Equity Alliance for Breast Cancer (THEAL), seeks to lower the Black/white breast cancer mortality gap in Harris County by 15% over the next decade.

Breast cancer overdiagnosis common among older women

A study of more than 50,000 women found that continued breast cancer screening after age 70 was associated with a greater incidence of cancer that likely would not have caused symptoms in the patient’s lifetime. These findings suggest that overdiagnosis may be common among older women who are diagnosed with breast cancer after screening. The study is published in Annals of Internal Medicine.

Study Uncovers Barriers to Mammography Screening Among Black Women

The study finds utilization of annual screening mammograms suboptimal among low-income Black women with several reported perceived and actual barriers. Most had a low breast cancer risk perception. Interestingly, participants perceived mammograms as very beneficial: 80 percent believed that ‘if breast cancer is found early, it’s likely that the cancer can be successfully treated;’ 90 percent indicated that ‘having a mammogram could help find breast cancer when it is first getting started.’

New ACR Breast Cancer Screening Guidelines call for earlier and more-intensive screening for high-risk women

New ACR breast cancer screening guidelines urge all women, particularly Black and Ashkenazi Jewish women, to have a risk assessment by age 25 to determine if screening before age 40 is needed. The ACR urges average-risk women to start yearly screening at 40, but earlier screening for high-risk women.

American Indian/Native American women have lower mammography use even if they have higher income

A new Harvey L. Neiman Health Policy Institute study found that for American Indian/Native American women, living in above-average-income communities was not associated with higher mammography use compared to American Indian/Native American women living in below-average-income communities.

NCCN Publishes New Patient Guidelines for Breast Cancer Screening and Diagnosis Emphasizing Annual Mammograms for All Average-Risk Women Over 40

The National Comprehensive Cancer Network (NCCN) has published new NCCN Guidelines for Patients: Breast Cancer Screening and Diagnosis to help people understand their personal risk for breast cancer, when they should begin screening, and how often to screen—in order to detect cancer earlier, for more treatment options and better outcomes.

MD Anderson Research Highlights for May 4, 2022

Featured studies include clinical advances with a new combination therapy targeting angiogenesis in platinum-resistant ovarian cancer and a promising immunotherapy combination for kidney cancer, plus laboratory studies that focus on targeting ferroptosis in specific lung cancers, developing chimeric antigen receptor (CAR) T cell therapies for blastic plasmacytoid dendritic cell neoplasms, and characterizing racial and ethnic disparities in breast cancer early detection.

The Greatest Gift for Mom: Health and Wellness

Now more than ever, we are reminded that health and wellness should always be a top priority. National Women’s Health Month and Mother’s Day, both celebrated in May, are important reminders that women can take control of their health by making feasible lifestyle choices and focusing on preventive care to lower the risk of certain cancers.

UChicago Medicine, in partnership with Solis Mammography, opens two new breast health centers

Solis Mammography, the nation’s largest independent provider of breast health and diagnostic services, is expanding access to 3D mammography and diagnostic breast health procedures through a partnership with University of Chicago Medicine.

Tackling Breast Cancer with Screening and Prevention

While researchers continue to make advances in breast cancer detection and treatment, one of the best ways to tackle the disease is through early detection and screening. Rutgers Cancer Institute expert shares more about risk factors, warning signs, and screening.

ACR, BCRF and GE Healthcare Announce Trial to Evaluate Use of Contrast Enhanced Mammography for Screening Women with Dense Breasts

In a new effort to improve early breast cancer detection and reduce false positive exams in women with dense breasts, the American College of Radiology, Breast Cancer Research Foundation and GE Healthcare are partnering to support the Contrast Enhanced Mammography Imaging Screening Trial (CMIST).